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Abstract It is increasingly recognised that genetics will
have to be integrated into all parts of primary health
care. Previous research has demonstrated that involve-
ment and confidence in genetics varies amongst primary
care providers. We aimed to analyse perceptions of
primary care providers regarding responsibility for
genetic tasks and factors affecting those perceptions.
Postal questionnaire including a hypothetical case man-
agement scenario of a cardiac condition with a genetic
component was sent to random samples of medically
qualified general practitioners in France, Germany,
Netherlands, Sweden and UK (n=1,168). Logistic regres-
sion analysis of factors affecting primary care practi-
tioners’ willingness to carry out genetic tasks themselves
was conducted; 61% would take a family history them-
selves but only 38% would explain an inheritance pattern
and 16% would order a genetic test. In multivariate
analysis, only the country of practice was consistently
predictive of willingness to carry out genetic tasks,
although male gender predicted willingness to carry out
the majority of tasks studied. The stage of career at which
education in genetics had been provided was not predic-
tive of willingness to carry out any of the tasks analysed.
Country of practice is significantly predictive of attitudes
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Background
Over the last decade, basic scientific research has led to a
greater understanding of the contribution made by genes to
present and future health (Guttmacher and Collins 2002). It
is increasingly recognised that genetic information will
need to be integrated into all aspects of health care delivery,
including primary care (Department of Health 2003;
Greendale and Pyeritz 2001; Harris and Harris 1995).
Patient advocacy groups have lobbied to raise health
professionals’ awareness of genetic issues (World Alliance
of Organizations for the Prevention of Birth Defects 2004),
and the need for both patients and professionals to have an
appropriate level of familiarity with the new technologies
has been recognised by the European Commission
(McNally et al. 2004).
Primary care providers have varying levels of involve-
ment and confidence in genetics (Emery et al. 1999). We
have demonstrated variable quality care provided for
genetic conditions by non-geneticists (Harris et al. 1999).
This has also been reported in Australia (Tyzack and
Wallace 2003), the Netherlands (Baars et al. 2003; van
Langen et al. 2003), Singapore (Yong et al. 2003), and USA
(Barrison et al. 2003; Batra et al. 2002; Schroy et al. 2002;
Taylor 2003). Core competencies for all health professio-
nals and particular professional groups are being developed
by expert panels (Calzone et al. 2002; Core Competency
Working Group of the National Coalition for Health
Professional Education in Genetics 2001;K i r ke ta l .
2003), and we have recently reported the educational
priorities of the healthcare providers themselves (Julian-
Reynier et al. 2008). A multiplicity of structures and
organisations are involved in training health professionals
in genetics (Challen et al. 2006, 2005; Henriksson and
Kristoffersson 2006; Julian-Reynier and Arnaud 2006;
Plass et al. 2006; Schmidtke et al. 2006). As part of a
larger study in five European countries, we examined the
self-reported behaviours and educational priorities of
primary care providers in situations where genetics was
relevant. This paper will present the results relating to
perceptions of professional responsibility for genetic care
amongst general practitioners, using hereditary cardiac
disease as an example of the “new” genetics in common
diseases. We aimed to analyse these attitudes and their
determining factors.
Methods
Sampling
As part of the larger GenEd (Genetic Education for
Nongenetic Health Professionals) study into educational
priorities in genetics for primary care providers, general
practitioners in France, Germany, Netherlands, Sweden and
UK were sent a self-administered questionnaire in early
2005. The sample size was calculated based on a 10%
precision (95% CI) for an educational outcome measure
(Calefato et al. 2008). Germany used a deliberate over-
sampling strategy because of the anticipated low response
rate. In France and UK, a random sample of a representa-
tive database was taken, in Germany a random sample of
MDs receiving reimbursement from sickness funds and
training MD students was taken, in the Netherlands
sampling was undertaken by the Netherlands Institute for
Health Services Research excluding those who had recently
participated in research and Sweden all general practitioners
were approached. Non-responders were sent at least one
reminder letter and, in some countries, were telephoned.
Questionnaire
The questionnaire was developed by a multidisciplinary
group including geneticists, primary care providers and
statisticians, initially in English. It was piloted in English
in each participating country, then translated and back-
translated to ensure consistency. Translated question-
naires were then re-piloted. As well as demographics,
the questionnaire included a hypothetical scenario relat-
ing to sudden cardiac death, a diagnosis chosen because
of the increasing recognition of genetic factors in its
aetiology (as demonstrated by its inclusion in the 2005
revision of the UK National Service Framework for
Heart Disease (Department of Health 2005)), but where
“traditional” genetic teaching is unlikely to have featured.
The text is shown in the text box. The vignette may have
provided new information to some respondents. We
wished to standardise their knowledge in order to interpret
their subsequent practice intentions, as we intended the
survey to be a pragmatic study of usual practice rather
than a specific test of knowledge of HOCM.
Box: text of the questionnaire scenario
MrSmith (aged35) attendsyoursurgerybecausehis 27-year-old brother,
a competitive swimmer, has just died suddenly. He collapsed in the pool
and despite defibrillation was found to be dead. Although sudden death
might not immediately suggest a genetic condition Mr Smith is worried
because his mother’s sister died suddenly aged 30 and he asks whether
the same may happened to him, his children Melanie (12 years), and
Tom (6 months) or his brother (32) or sister (24).
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hypertrophic obstructive cardiomyopathy (HCM), which can be
inherited as an autosomal dominant condition. 80% of non-traumatic
sudden deaths in young athletes are due to inherited or congenital
cardiovascular abnormalities and HCM accounts for 40–50% of these.
Genetic testing may lead to identification of patients at high risk for
sudden death as early as 10 years of age. Treatment can be
considered with implantable defibrillators or medication.
Respondents were asked who, in the scenario, should
perform the following tasks, with options being “myself
without seeking further information”, “myself after con-
sulting a journal or the web”, “myself after consulting a
colleague”, “a genetic specialist”, “a cardiologist”:
& Taking a family history
& Explaining the inheritance pattern
& Explaining the risk to the patient’s children
& Giving information about available gene tests
& Informing the patient of the implications if no mutation
were to be found
& Informing the patient of the implications if a mutation
were to be found
& Ordering the genetic test
& Explaining the test result
& Explaining the implications of the test result for the
patient’s children
Statistical analysis
Responses were entered into an SPSS v11.0 data sheet
using SNAP v7.0 questionnaire and scanning software. For
each task addressed in the questionnaire, the five possible
responses were dichotomised into “likely to do oneself” and
“should be done by a different professional”. Univariate
analysis was carried out for all tasks for association with:
country of practice, gender, age (over/under 50 years),
years in practice (under 10, 11–20, over 20), highest level
of education in genetics, and usefulness or otherwise of
continuing medical education, specialist training and
undergraduate training. Factors found to be predictive at
univariate analysis of “likely to do oneself” were entered
into multivariate stepwise logistic regression analysis using
a forward procedure (Wald test) (Hosmer and Lemeshow
2000). A type 1 error of <0.05 was chosen for the variables
to be included in the final model.
Ethics
Ethical approval was provided by the Eastern MREC (UK)
and appropriate approval was obtained in all countries.
Results
Overall, 1,168 (28.6%) practitioners responded (France 236
(48.7%), Germany 251 (20.8%), Netherlands 254 (37%),
Sweden 262 (38.7%), UK 165 (23.1%)). Demographics of
respondents are shown in Table 1. The highest level of
genetic education varied significantly (p<0.05) between
Table 1 Demographics of respondents (n varies due to incomplete
responses)
Characteristic Number (percentage)
Country of practice
France 236 (20.2)
Germany 251 (21.5)
Netherlands 254 (21.7)
Sweden 262 (22.4)
UK 165 (14.1)
Gender
Male 764 (65.4)
Female 404 (34.6)
Age group
≤50 years 572 (49.0)
>50 years 596 (51.0)
Years in practice
≤10 182 (15.6)
11–20 466 (39.9)
>20 520 (44.5)
Patients seen per week
<25 33 (2.9)
26–50 133 (11.5)
51–100 358 (31.0)
101–150 309 (26.8)
151–200 199 (17.2)
>200 122 (10.6)
Highest level of education in genetics
None 224 (19.2)
Undergraduate 680 (58.2)
During specialist training 53 (4.5)
CME 172 (14.7)
Further degree 32 (2.7)
Missing 7 (0.6)
Value of undergraduate training (n=880)
Useful 538 (61.1)
Useless 342 (38.9)
Value of specialist training (n=71)
Useful 61 (85.9)
Useless 10 (14.1)
Value of CME (n=172)
Useful 164 (95.3)
Useless 8 (4.7)
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were: Sweden 90%, UK 65%, Germany 60%, Netherlands
57% and France 50%. The highest level of genetic education
was also significantly associated with years spent in practice
(Table 2; χ
2=84.578, df=8, p<0.001).
Numbers of respondents willing to carry out each of the
tasks themselves is shown in Table 3. Most (61%) expected
to take a family history, and a significant minority (38%)
were willing to explain an inheritance pattern. However,
only 10.3 (28%) were willing to carry out any other tasks.
Univariate analysis of factors predicting likelihood of
carrying out tasks oneself is shown in Table 4. Factors
which remained significant at multivariate analysis are
shown in Table 5. Only country of practice and gender were
consistently predictive of willingness to carry out more
complex tasks, with French/German and male GPs showing
more willingness.
Discussion
Although most GPs (over 60%) would consider it part of
their role to take a family history, far fewer (less than 25%)
would be willing to discuss specific genetic tests or their
implications. Taking a family history is generally consid-
ered essential for the appropriate management of genetic
disorders. Thirty-eight per cent of GPs in this study felt that
this should be carried out by a specialist (either a geneticist
or a cardiologist).
The country of practice was the only consistent predictor
of GPs carrying out tasks themselves (with or without
reference to a textbook, the web or a colleague), with
French and German practitioners being more likely to do
so. There appear to be two different patterns: German,
Swedish and UK GPs were more likely to undertake initial
tasks (particularly taking a family history), with lessening
likelihood as the tasks became more complex, while French
and Dutch GPs tended either to carry out a significant
number of tasks or complete none and refer for the entire
genetic care “package”. It is unclear whether this reflects
varying awareness or availability of specialist genetic
services or varying willingness to refer to those services.
It is likely that the health service model in each country will
affect practitioners’ expectations of managing the patient
themselves or performing a gatekeeper role for secondary
care. It may also be that varying health service structures
restrict the availability of specific tests to non-specialist
practitioners.
At least 50% of GPs recalled receiving undergraduate
genetic education but this varied between countries.
However, less than 10% recalled receiving genetic educa-
tion during specialist training or continuing medical
education, suggesting that any formal genetic education
they had received was unlikely to have been up-to-date or
clinically relevant. We could hypothesise that the counter-
intuitive finding (see Table 2) of those practitioners who
had been practising longer having received more post-
specialist training in genetics represents a “catch-up”
phenomenon; those practitioners trained more recently
received the same information during undergraduate or
specialist training. The perceived usefulness of genetic
education as an undergraduate was a positive predictor of
likelihood to explain inheritance patterns, risks and gene
tests. This may reflect increased comfort in discussing
genetic issues amongst those practitioners who underwent
early engagement with genetics.
Being male appeared to increase the likelihood of
carrying out many genetic tasks, particularly the more
complex ones. There are several possible contributors to
this finding. The tasks we assessed were primarily
biomedical, and significant literature demonstrates the
tendency of male physicians to communicate biomedical
Undergraduate Specialist CME Degree None Total
≤10 years 130 16 19 4 12 181
11–20 years 309 18 60 10 65 462
>20 years 241 19 93 18 147 518
Total 680 53 172 32 224 1161
Table 2 Highest level of edu-
cation by years in practice
Table 3 Willingness to carry out tasks oneself
Task Number willing
to perform task
Percentage
Taking a family history 717 61.4
Explaining the inheritance pattern 445 38.1
Explaining the genetic risk to
Mr Smith’s children
327 28
Giving information about available
genetic tests
258 22.1
Informing Mr Smith of the implications
of no mutation being found
316 27.1
Informing Mr Smith of the implications
of a mutation being found
169 14.5
Ordering the genetic test 183 15.7
Explaining the test results 129 11
Explaining the implications of the test
results for Mr Smith’s children
120 10.3
86 J Community Genet (2010) 1:83–90Table 4 Univariate analysis
Task Variable Odds ratio for doing
oneself (95% CI)
Taking a family history Country (reference UK)
France 0.59 (0.39–0.90)
Germany 2.07 (1.33–3.23)
Netherlands 0.20 (0.13–0.30)
Sweden 2.41 (1.54–3.79)
Gender (reference male)
Female 1.25 (0.98–1.61)
Age (reference >50)
≤50 0.73 (0.57–0.92)
Years in practice (reference >20)
11–20 0.90 (0.69–1.16)
≤10 0.93 (0.66–1.32)
Highest genetic education (reference
none)
Undergraduate 1.45 (1.07–1.98)
During
specialist
training
1.67 (0.88–3.18)
CME 0.52 (0.35–0.78)
Value of genetic education (reference
useless)
Useful
undergraduate
0.96 (0.72–1.27)
Useful
specialist
0.41 (0.08–2.12)
Useful CME 0.23 (0.05–1.18)
Explaining the
inheritance pattern
Country (reference UK)
France 1.91 (1.26–2.89)
Germany 1.31 (0.87–1.98)
Netherlands 0.91 (0.59–1.38)
Sweden 1.48 (0.98–2.23)
Gender (reference male)
Female 1.05 (0.82–1.35)
Age (reference >50)
≤50 1.44 (1.14–1.83)
Years in practice (reference >20)
11–20 1.40 (1.08–1.81)
≤10 1.23 (0.87–1.74)
Highest genetic education (reference
none)
Undergraduate 1.48 (1.07–2.04)
During
specialist
training
1.96 (1.07–3.61)
CME 1.09 (0.71–1.67)
Value of genetic education (reference
useless)
Useful
undergraduate
1.55 (1.17–2.05)
Useful
specialist
1.45 (0.37–5.66)
Useful CME 0.84 (0.19–3.65)
Explaining the risk to
Mr Smith’s children
Country (reference UK)
France 2.95 (1.85–4.70)
Germany 1.64 (1.02–2.63)
Netherlands 1.31 (0.81–2.13)
Sweden 1.38 (0.85–2.21)
Table 4 (continued)
Task Variable Odds ratio for doing
oneself (95% CI)
Gender (reference male)
Female 0.64 (0.48–0.84)
Age (reference >50)
≤50 1.20 (0.93–1.55)
Years in practice (reference >20)
11–20 1.03 (0.78–1.36)
≤10 0.89 (0.61–1.31)
Highest genetic education (reference
none)
Undergraduate 1.05 (0.75–1.47)
During
specialist
training
1.49 (0.79–2.81)
CME 0.89 (0.57–1.40)
Value of genetic education (reference
useless)
Useful
undergraduate
1.50 (1.10–2.05)
Useful
specialist
training
1.62 (0.38–6.88)
Useful CME 0.56 (0.13–2.43)
Giving information about
available gene tests
Country (reference UK)
France 2.17 (1.30–3.63)
Germany 1.84 (1.10–3.07)
Netherlands 1.27 (0.75–2.16)
Sweden 1.59 (0.95–2.67)
Gender (reference male)
Female 0.63 (0.46–0.85)
Age (reference >50)
≤50 0.69 (0.52–0.91)
Years in practice (reference >20)
11–20 0.79 (0.59–1.07)
≤10 0.56 (0.36–0.88)
Highest genetic education (reference
none)
Undergraduate 0.87 (0.61–1.24)
During
specialist
training
1.10 (0.56–2.18)
CME 0.73 (0.45–1.19)
Value of genetic education (reference
useless)
Useful
undergraduate
1.48 (1.05–2.09)
Useful
specialist
training
3.77 (0.44–31.96)
Useful CME 0.73 (0.14–3.77)
Informing Mr Smith of the
implications if no mutation were
to be found
Country (reference UK)
France 4.01 (1.82–8.80)
Germany 23.97 (11.29–50.87)
Netherlands 7.76 (3.63–16.62)
Sweden 5.58 (2.59–12.03)
Gender (reference male)
Female 0.58 (0.43–0.77)
Age (reference >50)
≤50 1.06 (0.82–1.37)
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Task Variable Odds ratio for doing
oneself (95% CI)
Years in practice (reference >20)
11–20 1.02 (0.78–1.35)
≤10 0.65 (0.43–0.98)
Highest genetic education (reference
none)
Undergraduate 0.99 (0.71–1.40)
During
specialist
training
1.53 (0.81–2.88)
CME 1.09 (0.70–1.70)
Value of genetic education (reference
useless)
Useful
undergraduate
1.27 (0.93–1.74)
Useful
specialist
training
0.68 (0.17–2.69)
Useful CME 0.61 (0.14–2.66)
Informing Mr Smith of the
implications if a mutation
were to be found
Country (reference UK)
France 4.46 (1.83–10.89)
Germany 8.51 (3.58–20.20)
Netherlands 3.42 (1.39–8.42)
Sweden 4.64 (1.92–11.21)
Gender (reference male)
Female 0.52 (0.36–0.76)
Age (reference >50)
≤50 0.85 (0.61–1.18)
Years in practice (reference >20)
11–20 0.84 (0.60–1.18)
≤10 0.56 (0.33–0.96)
Highest genetic education (reference
none)
Undergraduate 1.32 (0.84–2.07)
During
specialist
training
1.49 (0.66–3.40)
CME 1.18 (0.66–2.13)
Value of genetic education (reference
useless)
Useful
undergraduate
1.36 (0.92–2.01)
Useful
specialist
training
1.77 (0.20–15.52)
Useful CME 0.23 (0.05–1.04)
Ordering the genetic test Country (reference UK)
France 2.16 (1.11–4.20)
Germany 3.33 (1.76–6.33)
Netherlands 1.76 (0.90–3.46)
Sweden 2.25 (1.17–4.33)
Gender (reference male)
Female 0.62 (0.43–0.88)
Age (reference >50)
≤50 0.85 (0.62–1.17)
Years in practice (reference >20)
11–20 0.94 (0.67–1.32)
≤10 0.72 (0.44–1.19)
Table 4 (continued)
Task Variable Odds ratio for doing
oneself (95% CI)
Highest genetic education (reference
none)
Undergraduate 1.24 (0.80–1.90)
During
specialist
training
0.92 (0.38–20.23)
CME 1.15 (0.66–2.02)
Value of genetic education (reference
useless)
Useful
undergraduate
1.29 (0.88–1.87)
Useful
specialist
training
0.35 (0.08–1.65)
Useful CME 0.55 (0.11–2.89)
Explaining the test result Country (reference UK)
France 5.45 (1.87–15.87)
Germany 10.24 (3.62–28.95)
Netherlands 3.55 (1.20–10.56)
Sweden 4.12 (1.41–12.08)
Gender (reference male)
Female 0.36 (0.22–0.57)
Age (reference >50)
≤50 0.73 (0.51–1.06)
Years in practice (reference >20)
11–20 0.86 (0.58–1.28)
≤10 0.68 (0.38–1.22)
Highest genetic education (reference
none)
Undergraduate 1.47 (0.88–2.45)
During
specialist
training
0.80 (0.26–2.46)
CME 0.90 (0.44–1.83)
Value of genetic education (reference
useless)
Useful
undergraduate
1.05 (0.69–1.60)
Useful
specialist
training
NA
Useful CME 0.25 (0.05–1.35)
Explaining the implications of
the test result for the children
Country (reference UK)
France 10.58 (2.48–45.19)
Germany 16.52 (3.94–69.25)
Netherlands 9.05 (2.12–38.70)
Sweden 7.21 (1.67–31.09)
Gender (reference male)
Female 0.47 (0.30–0.74)
Age (reference >50)
≤50 0.81 (0.56–1.19)
Years in practice (reference >20)
11–20 0.87 (0.58–1.31)
≤10 0.82 (0.46–1.44)
Highest genetic education (reference
none)
Undergraduate 1.05 (0.64–1.73)
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Also, the self-reporting nature of this study may be affected
by the tendency of female physicians to under-rate their
own competence (Nomura et al. 2010).
This is to our knowledge the first study in Europe of
primary care providers’ attitudes to genetic management
and how they relate to genetic education. Although the
response rate was not high, this is a common problem for
postal surveys and all appropriate methods were used to
increase the response rates. Databases from which
samples were taken varied slightly between countries,
but represented the only available national sources with
doctors’ addresses and specialties. We recognise that we
have studied self-reported rather than actual behaviour
but analysis of actual behaviour would have been
impossible to be organised practically and self-reporting
can be considered as a reliable proxy measure. Although
the scenario used related only to one condition, sudden
death from hypertrophic cardiomyopathy was selected as
a scenario diagnosis specifically because it was unlikely
to have featured in traditional Mendelian genetics
teaching. The importance of genetics in its aetiology is,
however, well recognised. We therefore suggest that it is
likely to be a good model for common complex disorders
with genetic aetiology encountered by primary care
providers.
We have previously demonstrated that genetic care by
non-geneticists is patchy and often poorly documented
(Lane et al. 1997; Williamson et al. 1997; Williamson et al.
1996a, b). This is supported by qualitative research which
found highly variable levels of information around referral
and testing for Factor V Leiden (Saukko et al. 2007) and
multiple potential barriers to effective communication
amongst GPs providing antenatal counselling (Nagle et al.
2008). Our work shows clearly that, apart from family
history taking, many European GPs do not consider that
“genetic” care should form part of their practice.
Conclusions
It is clear that given the significant effect of country of
practice, independent of all other factors, on practitioner
behaviour, recommendations on genetic education at all
levels will have to be sensitive to country-specific issues.
Educational structures and content will require tailoring to
local priorities and learning conventions. Any standards of
care for non-genetic specialists providing some aspects of
genetic care will need to be appropriately contextualised
into the local system of health care and health education
and it is unlikely that a pan-European “one size fits all”
policy will be immediately workable or acceptable.
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Table 4 (continued)
Task Variable Odds ratio for doing
oneself (95% CI)
During
specialist
training
0.88 (0.32–2.43)
CME 0.84 (0.42–1.66)
Value of genetic education (reference
useless)
Useful
undergraduate
1.30 (0.83–2.06)
Useful
specialist
training
0.98 (0.11–9.14)
Useful CME 0.69 (0.08–5.98)
Table 5 Multivariate analysis
Task Factors predictive
of doing it oneself
Wald score P
Taking a family
history
Country 193.05 <0.005
Explaining the inheritance
pattern
Country 25.68 <0.005
Age 7.12 0.008
Quality of
undergraduate
education
12.60 <0.005
Explaining the risk to
Mr Smith’s children
Country 24.04 <0.005
Quality of
undergraduate
education
7.12 0.008
Giving information about
available gene tests
Quality of
undergraduate
education
6.29 0.012
Gender 4.59 0.032
Age 6.40 0.011
Informing Mr Smith of the
implications if no mutation
were to be found
Country 93.09 <0.005
Gender 6.16 0.013
Informing Mr Smith of the
implications if a mutation
were to be found
Country 31.02 <0.005
Gender 9.51 0.002
Ordering the genetic test Country 15.07 0.005
Gender 7.22 0.007
Explaining the test result Country 29.24 <0.005
Gender 15.05 <0.005
Explaining the implications
of the test result for the
children
Country 19.51 0.001
Gender 7.93 0.005
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